Alfred P. Spada - Feb 1, 2023 Form 3 Insider Report for Histogen Inc. (HSTO)

Role
Executive Vice President and Chief Scientific Officer
Signature
/s/ Susan A. Knudson as attorney-in-fact for Alfred P. Spada, Ph.D.
Stock symbol
HSTO
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
3
Date filed
2/3/2023, 03:22 PM
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HSTO Common Stock 979 Feb 1, 2023 Direct
holding HSTO Common Stock 1.24K Feb 1, 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by a family trust of which Dr. Spada is a trustee.

Remarks:

Executive Vice President and Chief Scientific Officer